SOCS-1 is involved in TNF-α-induced mitochondrial dysfunction and apoptosis in renal tubular epithelial cells

2017 ◽  
Vol 49 (5) ◽  
pp. 537-544 ◽  
Author(s):  
Chunyang Du ◽  
Fang Yao ◽  
Yunzhuo Ren ◽  
Yunxia Du ◽  
Jinying Wei ◽  
...  
2001 ◽  
Vol 12 (11) ◽  
pp. 2288-2299 ◽  
Author(s):  
AKIO NAKAMURA ◽  
EDWARD J. JOHNS ◽  
AKIRA IMAIZUMI ◽  
YUKISHIGE YANAGAWA ◽  
TAKAO KOHSAKA

Abstract. Exposure of renal tubular epithelial cells to shiga toxin 2 (Stx-2) causes cytotoxicity, and the potency of this toxin is enhanced in the presence of tumor necrosis factor—α (TNF-α). It has been shown that Stx-2 induces TNF-α production and that activation of β2-adrenoceptors downregulates TNF-α. However, little is known about the signaling pathway by which β2-adrenoceptor agonists suppress the Stx-2—induced TNF-α gene transcription. The possible signaling components involved in this pathway were investigated. Human adenocarcinoma—derived renal tubular epithelial cells (ACHN) were exposed to Stx-2 in the presence or absence of a β2-adrenoceptor agonist. Mitogen-activated protein kinase (MAPK), activating protein—1 (AP-1), and nuclear factor—κB (NF-κB) were measured to evaluate the regulatory mechanisms involved in TNF-α gene transcription. Stx-2 (4 pg/ml) stimulated MAPK (p42/p44, p38) and AP-1 and increased TNF-α promoter activity by 2.4-fold. The increase in TNF-α was attenuated by both a p42/p44 inhibitor, PD098059 (10-6 M), and a p38 inhibitor, SB203580 (10-6 M), and AP-1—binding activity was inhibited by PD098059. Terbutaline (10-6 M to 10-8 M) suppressed MAPK (p42/p44, p38), NF-κB (p50, p65), and TNF-α promoter activity in a dose-dependent way that was prevented by the β2-adrenoceptor antagonist, ICI118,551. However, inhibition of MAPK (p42/p44) and TNF-α promoter activity was partially prevented by the cAMP-protein kinase (PKA) inhibitors, H-89 (5 × 10-6 M) and KT5720 (10-5 M), whereas the suppression of p38 MAPK or NF-κB (p50) was not blocked by these inhibitors. The suppression of NF-κB (p65) was completely overcome by H-89 or KT5720. In summary, the downregulation of TNF-α transcription by terbutaline was mediated by an inhibitory effect of β2-adrenoceptor activation on MAPK (p42/p44, p38) and NF-κB (p50/p65), which were exerted through a cAMP-PKA pathway and a cAMP-independent mechanism. It is likely that cAMP-PKA and MAPK (p42/p44, p38) may play a critical role in the regulation of the Stx-2—induced TNF-α transcription via β2-adrenoceptor activation.


2012 ◽  
Vol 54 (1) ◽  
pp. 92-100 ◽  
Author(s):  
Jianxin Wan ◽  
Xueli Zhou ◽  
Jiong Cui ◽  
Zhenhuan Zou ◽  
Yanfang Xu ◽  
...  

2006 ◽  
Vol 26 (4) ◽  
pp. 356-362 ◽  
Author(s):  
Ya Jie Zhang ◽  
Xiao Yang ◽  
Qing Yu Kong ◽  
Yun Fang Zhang ◽  
Wei Ying Chen ◽  
...  

2015 ◽  
Vol 467 (1) ◽  
pp. 63-69 ◽  
Author(s):  
Takayuki Adachi ◽  
Mitsumi Arito ◽  
Naoya Suematsu ◽  
Atsuko Kamijo-Ikemori ◽  
Kazuki Omoteyama ◽  
...  

2007 ◽  
Vol 293 (3) ◽  
pp. F801-F812 ◽  
Author(s):  
Kanishka Mohib ◽  
Qiunong Guan ◽  
Hong Diao ◽  
Caigan Du ◽  
Anthony M. Jevnikar

Exposure of renal tubular epithelial cells (TEC) to IFN-γ/TNF-α leads to Fas/FasL-mediated self-injury, which contributes to allograft rejection. Indoleamine 2,3-dioxygenase (IDO) converts tryptophan to N-formyl-kynurenine and contributes to immune privilege in tissues by increasing Fas-mediated T cell apoptosis. However, renal expression of IDO and its role in promoting Fas-mediated TEC death have not been examined. IDO expression was analyzed by RT-PCR and Western blot. Apoptosis was measured by fluorescence-activated cell sorting analysis and terminal deoxytransferase-mediated dUTP nick end labeling. We demonstrated that functional IDO is expressed in TEC and is increased by IFN-γ/TNF-α exposure. Increased IDO activity promoted TEC apoptosis, whereas inhibition of IDO by its specific inhibitor 1-methyl-d-tryptophan attenuated IFN-γ/TNF-α-mediated TEC apoptosis and augmented TEC survival. Transgenic expression of IDO resulted in increased TEC apoptosis in the absence of proinflammatory cytokine exposure, supporting a central role for IDO in TEC injury. Inhibition of IDO-mediated TEC death by a caspase-8-specific inhibitor (Z-IETD-FMK), as well as the absence of an IDO effect in Fas-deficient and FasL-deficient TEC, supports a Fas/FasL-dependent, caspase-8-mediated mechanism for IDO-enhanced TEC death. These data suggest that renal IDO expression may be deleterious during renal inflammation, because it enhances TEC self-injury through Fas/FasL interactions. Thus attenuation of IDO may represent a novel strategy to promote kidney function following ischemia and renal allograft rejection.


Sign in / Sign up

Export Citation Format

Share Document